Post by Courtney Rice

Vinay Prasad left CBER on April 30, 2026. Marty Makary stopped heading FDA on May 12, 2026. Last week uniQure got clearance to submit their BLA for a gene therapy in Huntington's disease. Today, Jason Mast's story on Regenxbio and the FDA's change of heart around MPS II / Hunter Syndrome. It's almost like Peter Marks is back. He's not, but I'm a solid believer in manifesting. https://lnkd.in/giVdUY3j